Key points are not available for this paper at this time.
A significant proportion of kidney transplants show a high HLA sensitization and should be considered for transplantation across the HLA barrier. The best strategy to manage these patients is still a matter of debate and the benefits of desensitization based on apheresis techniques, intravenous immunoglobulins and rituximab have not been clearly delineated.
Moreno et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: